Nang Kuang Pharmaceutical Co., Ltd.

TWSE:1752.TW

43.4 (TWD) • At close October 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 213.678410.626234.76223.608250.824117.737217.665270.205226.62882.5965.70280.3746.162-10.58511.936
Depreciation & Amortization 181.963176.281179.75185.289192.995196.206178.109171.68163.975152.577121.17106.91999.2384.95169.248
Deferred Income Tax 00000.066000-25.5010-20.506000-5.41
Stock Based Compensation 000010.1380005.0960.0015.4850000.024
Change In Working Capital -114.772-95.337131.786-220.444-60.77354.862-25.998-1.985-33.682-7.521-52.273-25.834-68.154-10.89714.869
Accounts Receivables -66.777-38.53229.75-4.0969.88324.45-68.53633.104-22.874-15.05-66.0030000
Inventory 71.528-130.21480.128-189.058-160.075-0.076-26.022-8.724-49.14-54.955-50.756-17.731-50.387-5.219-2.625
Accounts Payables -87.53330.32736.01-38.37175.67580.886.011-6.49515.75000000
Other Working Capital -31.9943.082-14.10211.08113.74454.9380.0246.73915.45847.434-1.517-8.103-17.767-5.67817.494
Other Non Cash Items 61.736-122.38410.332-37.446-7.056-2.685-47.068-34.91-13.784-2.823.10.45713.4344.3290.521
Operating Cash Flow 342.605369.186556.628151.007386.194366.12322.708404.99348.233224.83283.184161.91650.67267.79896.598
Investing Activities:
Investments In Property Plant And Equipment -300.731-94.165-159.741-91.685-74.984-155.738-204.548-229.419-298.785-107.565-188.228-365.191-218.71-242.435-241.405
Acquisitions Net 6.525-0.0890.0460000.060.0380000000
Purchases Of Investments -33.751-20-129.2-25.20600-19.5-23.268-10-2400000
Sales Maturities Of Investments -6.5251.7797.80000000001.39500
Other Investing Activites 4.9732.622-10.3874.885-1.2411.32-6.048-5.779-9.867-10.095-9.457-0.8741.6060.34-1.919
Investing Cash Flow -329.509-109.853-291.482-112.006-76.225-154.418-229.875-252.365-314.344-135.401-195.29-365.937-215.219-242.095-242.949
Financing Activities:
Debt Repayment -2,322.5-2,932.5-2,427-3,155-52-197.912-53-391.5-43-82-905.520000
Common Stock Issued 30.29725.24710.09950.49427.15627.1560023.8490323.19000109.365
Common Stock Repurchased -30.297-25.247-10.099-50.49423.21-27.156-60.593-60.1710-23.84900000
Dividends Paid -201.977-156.532-151.483-121.186-90.066-161.582-161.582-60.171-44.582-24.999-22.415-12.60-12.6-55.501
Other Financing Activities 2,488.7112,813.7182,464.0043,111.71-2.866-27.156126.967357.77428.84994.99771202.6510201.85359.545
Financing Cash Flow -35.766-275.314-114.479-164.476-94.566-386.65-87.615-93.89727.267-10.859166.255190.051217.855189.253113.409
Other Information:
Effect Of Forex Changes On Cash -0.0550.058-0.006-0.013-0.0030.0030.005-0.0220000000
Net Change In Cash -22.725-15.923150.661-125.488215.4-174.9455.22358.70661.15678.57254.149-13.9753.30814.956-32.942
Cash At End Of Period 378.475401.2417.123266.462391.95176.55351.495346.272287.566226.41147.83893.689107.65954.35139.395